Making the Case for Universal Treatment of Hypercholesterolemia

Am J Cardiol. 2016 Jul 15;118(2):303-4. doi: 10.1016/j.amjcard.2016.04.027. Epub 2016 May 5.

Authors

Abhishek Goyal¹, Tanush Gupta¹, Wilbert S Aronow¹, Julio A Panza¹, Howard A Cooper²

Affiliations

¹ Division of Cardiology, Department of Medicine, New York Medical College, Valhalla, New York.
² Division of Cardiology, Department of Medicine, New York Medical College, Valhalla, New York. Electronic address: Howard.Cooper@WMCHealth.org.

PMID: 27236257
DOI: 10.1016/j.amjcard.2016.04.027

No abstract available

Publication types

Editorial

MeSH terms

Adult
Aged
Anticholesteremic Agents / therapeutic use*
Atherosclerosis / epidemiology
Atherosclerosis / etiology
Atherosclerosis / prevention & control
Female
Humans
Hypercholesterolemia / complications
Hypercholesterolemia / therapy*
Incidence
Male
Mass Screening*
Middle Aged
Risk Factors
United States / epidemiology
Young Adult

Substances

Anticholesteremic Agents